Rojas-Marcos, IñigoGraus Ribas, FrancescKeine-Guibert, FlorenceReñé Ramírez, RamonDelattre, Jean YvesRamon Torrell, Josep M. (Josep Maria)Dalmau Obrador, JosepPosner, Jerome B.2021-06-092021-06-0920000028-3878https://hdl.handle.net/2445/178218The outcome of 34 women with anti-Yo-associated paraneoplastic cerebellar degeneration was reviewed. Three patients had not developed cancer after more than 4 years of follow-up. The only independent predictor for survival was the type of associated tumor (risk ratio, 1.79; 95% CI, 1.02 to 3.12). Median survival was 100 months for patients with breast cancer and 22 for those with gynecologic cancer. Although paraneoplastic cerebellar degeneration leads to the diagnosis of cancer in 63% of the patients, cancer progression was the cause of death in 52%.3 p.application/pdfeng(c) American Academy of Neurology, 2000FisiologiaPatologiaCerebelDegeneració (Patologia)PhysiologyPathologyCerebellumDegeneration (Pathology)info:eu-repo/semantics/article1777862021-06-09info:eu-repo/semantics/openAccess10980743